# Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

> **NCT01712360** · PHASE4 · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Tinea Pedis
- Tinea Cruris

## Interventions

- **DRUG:** NAFT500 (pediatric)
- **DRUG:** NAFT600 (pediatric)
- **DRUG:** NAFT500 (adult)
- **DRUG:** NAFT600 (adult)

## Key facts

- **NCT ID:** NCT01712360
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01712360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01712360, "Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01712360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*